Reference
Prasad V, et al. Lu-177 DKFZ-617 PSMA for treatment of patients with progressive prostate cancer: Toxicity, efficacy and survival. Nuklearmedizin 56: A38, No. 2, Jan 2017 [abstract] - Germany
Rights and permissions
About this article
Cite this article
PSMA-617. Reactions Weekly 1697, 340 (2018). https://doi.org/10.1007/s40278-018-44896-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-44896-5